Lupin Biologics Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 94.51%
- Ebitda 94.51%
- Net Worth -37.49%
- Total Assets -81.40%
About Lupin Biologics
Lupin Biologics Limited (LBL) is a Public Limited Indian Non-Government Company incorporated in India on 28 January 2021 (Four years and three months 3 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vinita Gupta, Nilesh Gupta, and Swaminathan Ramesh serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299MH2021PLC354211
- Company No.
354211
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2021
- Date of AGM
15 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Life Sciences
Lupin Biologics Limited
Explore comprehensive data for Lupin Biologics Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Lupin Biologics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinita Gupta  | Director | 28-Jan-2021 | Current |
| Swaminathan Ramesh | Director | 28-Jan-2021 | Current |
| Nilesh Gupta | Director | 28-Jan-2021 | Current |
Financial Performance of Lupin Biologics.
Lupin Biologics Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.51% increase in profit. The company's net worth observed a substantial decline by a decrease of 37.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lupin Biologics?
In 2021, Lupin Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lupin Digital Health LimitedNilesh Gupta and Swaminathan Ramesh are mutual person
Lupin LimitedVinita Gupta, Nilesh Gupta and 1 more are mutual person
Lupin Diagnostics LimitedNilesh Gupta and Swaminathan Ramesh are mutual person
Lupin Investments Private LimitedVinita Gupta and Nilesh Gupta are mutual person
Polynova Industries LimitedNilesh Gupta is a mutual person
Synchem Properties Private LimitedVinita Gupta and Nilesh Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lupin Biologics?
Lupin Biologics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lupin Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupin Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Lupin Biologics
Recent activity within the organization
- Annual General Meeting
Lupin Biologics Limited last Annual general meeting of members was held on 15 Jul 2024 as per latest MCA records.
- Balance Sheet
Lupin Biologics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Vinita Deshbandhu Gupta was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 4 years 3 months .
- Director Appointment
Nilesh Deshbandhu Gupta was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 4 years 3 months .
- Director Appointment
Swaminathan Ramesh was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 4 years 3 months .
- Company Incorporation
Lupin Biologics Limited was registered on 28 Jan 2021 with Roc Mumbai & aged 4 years 3 months as per MCA records.
Recent News, Updates & Announcement
Lupin appoints Christoph Funke as new CTO.Funke has previously worked in leadership roles at organisations such as Fresenius Kabi and Strides Pharma Science. In his leadership roles, Funke has managed large-scale technical operations and manufacturing networks across 27 sites in 19 countries, overseeing production value exceeding $ 2 billion and leading teams of over 12,500 employees, the press release said. Funke holds an engineering degree from South Westphalia University of Applied Sciences, Germany..
- Lupin gets USFDA nod to market generic drug to treat diabetes.
The product is a generic equivalent of AstraZeneca AB's Qtern tablets.
- Facing regulator’s heat, Lupin shows urgency with quality control hire | Mint.
Whether Johnny Mikell will be given enough authority to steer the ship will be an important factor, say analysts.Resolving the issues soon will be crucial for the company, considering that further delays would make it more prominent on US FDA’s heat map.
Frequently asked questions
What is the Incorporation or founding date of Lupin Biologics Limited?
Lupin Biologics Limited was incorporated on 28 Jan 2021.
What is authorized share capital and paid-up capital of Lupin Biologics Limited?
The authorized share capital of Lupin Biologics Limited is ₹ 10.00 Cr and paid-up capital is ₹ 1.50 M.
Who are the current board members & directors of Lupin Biologics Limited?
Currently 3 directors are associated with Lupin Biologics Limited.
- Vinita Deshbandhu Gupta
- Nilesh Deshbandhu Gupta
- Swaminathan Ramesh
What is the registered address of Lupin Biologics Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Lupin Biologics Limited is Kalpataru Inspire 3Rd Floor Off Western Express Highway, Santacruz East India, Mumbai, Maharashtra, 400055.
What is the corporate identification number (CIN) and company number of Lupin Biologics Limited?
The corporate identification number (CIN) of Lupin Biologics Limited is U24299MH2021PLC354211 and the company number is 354211 as per Ministry of Corporate Affairs (MCA).
What is the official website of Lupin Biologics Limited?
The Official website of Lupin Biologics Limited is https://www.lupin.com
What change has been observed in the net worth of Lupin Biologics Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Lupin Biologics Limited has experienced an downturn of -37.49%.
When was the last Balance Sheet of Lupin Biologics Limited filed with the ROC?
The most recent Balance Sheet for Lupin Biologics Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records